OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 460,642 shares at $0.60 ($276K) on 2024-12-20, disclosed to the SEC on 2024-12-26.
Open-market sale of $276k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.60 | 230,321 | $138K | 50.0% |
| 2 | $0.60 | 230,321 | $138K | 50.0% |
| Total | $0.60 avg | 460,642 | $276K | 100% |
| Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |
| ELVN | SELL | 2024-05-20 | $22.9M | — | Filing → |